91 results
Page 2 of 5
6-K
quc5uiqwimza
8 Jul 22
Current report (foreign)
4:05pm
6-K
EX-99.2
xub2of8vfxjm
2 Jun 22
Notice of Annual General Meeting of Shareholders
5:00pm
6-K
EX-99.1
cus644a
2 Jun 22
Notice of Annual General Meeting of Shareholders
5:00pm
6-K
EX-99.3
gjpp rg7275
17 May 22
VBL Therapeutics Reports First Quarter 2022 Financial Results
7:00am
6-K
EX-99.1
s5mm ch38ox5epecu2m
15 Feb 22
Current report (foreign)
4:27pm
424B5
f4w8 02zsou
11 Feb 22
Prospectus supplement for primary offering
5:28pm
6-K
hf6m3cdc
20 Oct 21
Current report (foreign)
4:01pm
6-K
EX-99.2
fsu9vys6 ak
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
6-K
EX-99.1
xbv8eba mkq75jtc
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
6-K
ej8kqy 5k8reiox
16 Aug 21
Current report (foreign)
7:00am
6-K
htdu0 135
11 May 21
Current report (foreign)
7:00am
POS AM
r9j3370
19 Apr 21
Prospectus update (post-effective amendment)
5:17pm
424B8
3bbz5
19 Apr 21
Prospectus unintentially filed late
5:06pm
424B5
tt1dzvk
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
unclag2
9 Apr 21
Prospectus supplement for primary offering
12:00am
424B5
dyrivs9rpzbmzlzy8wr
15 Jan 21
Prospectus supplement for primary offering
7:00am